Shelley Gilbert
Medical · Myrtle Beach, SCNPI 1467698621
Payments from drug & device makers
Across 98 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$319
- AstraZeneca$206
- Novo Nordisk$143
- AbbVie$143
- Astellas Pharma US Inc$104
- Pfizer$86
- plus $734 from 20 others
What the payments were for
- Food & beverage$1,736100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,736 in reported general payments places this provider in the 60th percentile of 384 medical providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 99 | $139,613 |
| OzempicSemaglutide | 97 | $117,356 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 105 | $108,191 |
| JardianceEmpagliflozin | 62 | $75,098 |
| EliquisApixaban | 61 | $74,679 |
| LinzessLinaclotide | 21 | $29,703 |
| FarxigaDapagliflozin Propanediol | 29 | $27,107 |
| Tresiba Flextouch U-200Insulin Degludec | 26 | $22,116 |
| XareltoRivaroxaban | 15 | $16,232 |
| JanuviaSitagliptin Phosphate | 14 | $10,335 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $6,008 |
| Rosuvastatin Calcium | 364 | $5,261 |
| Levothyroxine Sodium | 457 | $5,245 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 142 | $5,169 |
| InvokanaCanagliflozin | 11 | $5,140 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $319 | $139,61399 claims |
| Novo NordiskOzempic | $143 | $117,35697 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $47 | $114,199116 claims |
| PfizerEliquis | $86 | $74,67961 claims |
| AbbVieLinzess, Synthroid | $143 | $31,30444 claims |
| AstraZenecaFarxiga | $206 | $27,10729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 384 medical providers in South Carolina.
Other medical in Myrtle Beach
- Lindsay JohnsonMyrtle Beach$11K
- Bleselda ParagasMyrtle Beach$8K
- Tanya BralleyMyrtle Beach$7K
- Sanford HardinMyrtle Beach$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.